Hypoglossal Nerve Stimulator Implantation Safe for OSA in Children With Down Syndrome

Follow Drugslib on

By Elana Gotkine HealthDay Reporter

Medically reviewed by Carmen Pope, BPharm. Last updated on Aug 15, 2025.

via HealthDay

FRIDAY, Aug. 15, 2025 -- For children aged younger than 13 years with Down syndrome (DS) and severe obstructive sleep apnea (OSA), hypoglossal nerve stimulator (HGNS) implantation is safe and effective, according to a study published online in the September issue of the International Journal of Pediatric Otorhinolaryngology.

Minjee Kim, M.D., from Harvard Medical School in Boston, and colleagues conducted a retrospective cohort study at two academic institutions to examine the safety and efficacy of HGNS placement in children younger than 13 years of age with DS and severe OSA. The study included 29 children (median age, 10 years; 19 were male).

The researchers found that all children were safely implanted with no serious adverse events. One mild wound dehiscence occurred, which resolved with antibiotic ointment and pressure dressing; there were no adverse device effects. The median preop and postop obstructive apnea hypopnea index (OAHI) was 18.4 and 3.9, respectively. Twenty patients (95.2 percent) had an OAHI reduction of 50 percent or more at six months postop.

"This research has major implications, first being that the safety results can alleviate concerns about whether this procedure is possible in young children," coauthors Christopher Hartnick, M.D., from Mass Eye and Ear in Boston, and Brian Skotko, M.D., from Massachusetts General Hospital in Boston, said in a statement. "We also feel this research offers a message of hope to parents of young children with Down syndrome who have worried about their children’s sleep apnea."

Abstract/Full Text (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Posted : 2025-08-16 12:00

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords